The obesity duopoly has been pierced as Amgen positions itself to have a drug on the market in a few years. While this adds ...

A highly anticipated obesity-drug candidate from biotech Amgen helped patients shed a significant amount of weight in a midstage study. Subjects taking Amgen's MariTide lost 20% of their body weight ...

Amgen's experimental drug MariTide helped overweight or obese patients lose up to 20% weight on average in a year-long ...

The proposed rule could give millions of Americans access to the new drugs; it will also put pressure on the incoming Trump administration.

In fact, Viking just gave investors an update which firms up its status as a very promising company. Here's what it reported, ...

Mounjaro is a treatment for Type 2 diabetes that activates GIP and GLP-1 pathways to help regulate blood sugar. It’s part of ...

Investors are assessing the likelihood Trump will deliver on his threat to impose fresh tariffs on China, Canada and Mexico.

Novo Nordisk announced today that Wegovy® (semaglutide injection) is now approved to reduce the risk of non-fatal myocardial infarction in adults with established cardiovascular disease and ...

While a region’s economic growth seldom maps readily onto stock market growth, there are times when specific areas appear to ...

The contingent of celebrants at the afternoon news conference was led by Gov. Pat McCrory, who praised Novo Nordisk as a valuable corporate citizen. An article in the May, 2015 issue of Site Selection ...